GPVI and CLEC-2

Platelets, Third Edition

Volumn , Issue , 2012, Pages 215-231

  Pollitt, Alice Y ^a   Hughes, Craig E ^a   Watson, Steve P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975266304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-387837-3.00011-0     Document Type: Chapter

References (133)

1. S.P. Watson, J.M. Auger, O.J. McCarty and A.C. Pearce (2005) GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 3(8), 1752-1762.
2. S.P. Watson, J.M. Herbert and A.Y. Pollitt (2010) GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 8(7), 1456-1467.
3. A. Strzelecka, K. Kwiatkowska and A. Sobota (1997) Tyrosine phosphorylation and Fcgamma receptor-mediated phagocytosis. FEBS Lett 400(1), 11-14.
4. D. Cox, S.W. Kerrigan and S.P. Watson (2011) Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 9(6), 1097-1107.
5. B. Boylan, C. Gao, V. Rathore, J.C. Gill, D.K. Newman, P.J. Newman, et al. (2008) Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets. Blood 112(7), 2780-2786.
6. M.P. Reilly, U. Sinha, P. Andre, S.M. Taylor, Y. Pak, F.R. Deguzman, et al. (2011) PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. Blood 117(7), 2241-2246.
7. A.D. Barrow and J. Trowsdale (2006) You say ITAM and I say ITIM, let’s call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 36(7), 1646-1653.
8. J.M. Gibbins (2002) The negative regulation of platelet function: extending the role of the ITIM. Trends Cardiovasc Med 12(5), 213-219.
9. J. Mori, A.C. Pearce, J.C. Spalton, B. Grygielska, J.A. Eble, M.G. Tomlinson, et al. (2008) G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem 283(51), 35419-35427.
10. D.R. Phillips and P.P. Agin (1977) Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. J Biol Chem 252(6), 2121-2126.
11. K. Furihata, K.J. Clemetson, H. Deguchi and T.J. Kunicki (2001) Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity. Arterioscler Thromb Vasc Biol 21(11), 1857-1863.
12. D. Best, Y.A. Senis, G.E. Jarvis, H.J. Eagleton, D.J. Roberts, T. Saito, et al. (2003) GPVI levels in platelets: relationship to platelet function at high shear. Blood 102(8), 2811-2818.
13. F.F. Samaha, C. Hibbard, J. Sacks, H. Chen, M.A. Varello, T. George, et al. (2005) Density of platelet collagen receptors glycoprotein VI and alpha2beta1 and prior myocardial infarction in human subjects, a pilot study. Med Sci Monit 11(5), CR224-CR229.
14. Y.A. Senis, M.G. Tomlinson, S. Ellison, A. Mazharian, J. Lim, Y. Zhao, et al. (2009) The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood 113(20), 4942-4954.
15. T. Sugiyama, M. Okuma, F. Ushikubi, S. Sensaki, K. Kanaji, H. Uchino, et al. (1987) A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 69(6), 1712-1720.
16. M. Moroi, S.M. Jung, M. Okuma and K. Shinmyozu (1989) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84(5), 1440-1445.
17. J. Gibbins, J. Asselin, R. Farndale, M. Barnes, C.L. Law, S.P. Watson, et al. (1996) Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem 271(30), 18095-18099.
18. J.M. Gibbins, M. Okuma, R. Farndale, M. Barnes and S.P. Watson (1997) Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett 413(2), 255-259.
19. A. Poole, J.M. Gibbins, M. Turner, M.J. van Vugt, J.G. van de Winkel, T. Saito, et al. (1997) The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16(9), 2333-2341.
20. R. Ryo, A. Yoshida, W. Sugano, M. Yasunaga, K. Nakayama, K. Saigo, et al. (1992) Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. Am J Hematol 39(1), 25-31.
21. M. Arai, N. Yamamoto, M. Moroi, N. Akamatsu, K. Fukutake, K. Tanoue, et al. (1995) Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol 89(1), 124-130.
22. H. Takahashi and M. Moroi (2001) Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus. Am J Hematol 67(4), 262-267.
23. C. Hermans, C. Wittevrongel, C. Thys, P.A. Smethurst, C. Van Geet, K. Freson, et al. (2009) A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost 7(8), 1356-1363.
24. B. Dumont, D. Lasne, C. Rothschild, M. Bouabdelli, V. Ollivier, C. Oudin, et al. (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114(9), 1900-1903.
25. J. Polgar, J.M. Clemetson, B.E. Kehrel, M. Wiedemann, E.M. Magnenat, T.N. Wells, et al. (1997) Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 272(21), 13576-13583.
26. M. Jandrot-Perrus, S. Busfield, A.H. Lagrue, X. Xiong, N. Debili, T. Chickering, et al. (2000) Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96(5), 1798-1807.
27. J.M. Clemetson, J. Polgar, E. Magnenat, T.N. Wells and K.J. Clemetson (1999) The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 274(41), 29019-29024.
28. Y. Miura, M. Ohnuma, S.M. Jung and M. Moroi (2000) Cloning and expression of the platelet-specific collagen receptor glycoprotein VI. Thromb Res 98(4), 301-309.
29. Y. Ezumi, T. Uchiyama and H. Takayama (2000) Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI. Biochem Biophys Res Commun 277(1), 27-36.
30. M.G. Tomlinson, S.D. Calaminus, O. Berlanga, J.M. Auger, T. Bori-Sanz, L. Meyaard, et al. (2007) Collagen promotes sustained glycoprotein VI signaling in platelets and cell lines. J Thromb Haemost 5(11), 2274-2283.
31. L. Meyaard (2008) The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 83(4), 799-803.
32. R.J. Lebbink, T. de Ruiter, J. Adelmeijer, A.B. Brenkman, J.M. van Helvoort, M. Koch, et al. (2006) Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 203(6), 1419-1425.
33. R.K. Andrews, K. Suzuki-Inoue, Y. Shen, D. Tulasne, S.P. Watson and M.C. Berndt (2002) Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 99(11), 4219-4221.
34. K. Suzuki-Inoue, D. Tulasne, Y. Shen, T. Bori-Sanz, O. Inoue, S.M. Jung, et al. (2002) Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem 277(24), 21561-21566.
35. O. Berlanga, T. Bori-Sanz, J.R. James, J. Frampton, S.J. Davis, M.G. Tomlinson, et al. (2007) Glycoprotein VI oligomerization in cell lines and platelets. J Thromb Haemost 5(5), 1026-1033.
36. B. Nieswandt, W. Bergmeier, V. Schulte, K. Rackebrandt, J.E. Gessner, H. Zirngibl, et al. (2000) Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem 275(31), 23998-24002.
37. Y. Miura, T. Takahashi, S.M. Jung and M. Moroi (2002) Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 277(48), 46197-46204.
38. S.M. Jung, K. Tsuji and M. Moroi (2009) Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: direct evidence obtained with dimeric GPVI-specific Fabs. J Thromb Haemost 7(8), 1347-1355.
39. M. Zahid, S. Loyau, M. Bouabdelli, N. Aubrey, M. Jandrot-Perrus and P. Billiald (2011) Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential. Anal Biochem 417(2), 274-282.
40. K. Horii, M.L. Kahn and A.B. Herr (2006) Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood 108(3), 936-942.
41. P.A. Smethurst, D.J. Onley, G.E. Jarvis, M.N. O’Connor, C.G. Knight, A.B. Herr, et al. (2007) Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine–proline–hydroxyproline triplets. J Biol Chem 282(2), 1296-1304.
42. P.A. Smethurst, L. Joutsi-Korhonen, M.N. O’Connor, E. Wilson, N.S. Jennings, S.F. Garner, et al. (2004) Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103(3), 903-911.
43. J. Feng, D. Garrity, M.E. Call, H. Moffett and K.W. Wucherpfennig (2005) Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immun 22(4), 427-438.
44. L.F. Morton, A.R. Peachey and M.J. Barnes (1989) Platelet-reactive sites in collagens type I and type III: evidence for separate adhesion and aggregatory sites. Biochem J 258(1), 157-163.
45. S.A. Santoro, J.J. Walsh, W.D. Staatz and K.J. Baranski (1991) Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation. Cell Regul 2(11), 905-913.
46. S. Watson, O. Berlanga, D. Best and J. Frampton (2000) Update on collagen receptor interactions in platelets: is the two-state model still valid? Platelets 11(5), 252-258.
47. B Nieswandt, C. Brakebusch, W. Bergmeier, V. Schulte, D. Bouvard, R. Mokhtari-Nejad, et al. (2001) Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 20(9), 2120-2130.
48. P.R. Siljander, S. Hamaia, A.R. Peachey, D.A. Slatter, P.A. Smethurst, W.H. Ouwehand, et al. (2004) Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem 279(46), 47763-47772.
49. J.M. Auger, M.J. Kuijpers, Y.A. Senis, S.P. Watson and J.W. Heemskerk (2005) Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J 19(7), 825-827.
50. L.F. Morton, P.G. Hargreaves, R.W. Farndale, R.D. Young and M.J. Barnes (1995) Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J 306(Pt. 2), 337-344.
51. J Asselin, J.M. Gibbins, M. Achison, Y.H. Lee, L.F. Morton, R.W. Farndale, et al. (1997) A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1. Blood 89(4), 1235-1242.
52. B. Kehrel, S. Wierwille, K.J. Clemetson, O. Anders, M. Steiner, C.G. Knight, et al. (1998) Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 91(2), 491-499.
53. M. Jandrot-Perrus, A.H. Lagrue, M. Okuma and C. Bon (1997) Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1. J Biol Chem 272(43), 27035-27041.
54. M.T. Murakami, S.P. Zela, L.M. Gava, S. Michelan-Duarte, A.C. Cintra and R.K. Arni (2003) Crystal structure of the platelet activator convulxin, a disulfide-linked alpha4beta4 cyclic tetramer from the venom of Crotalus durissus terrificus. Biochem Biophys Res Commun 310(2), 478-482.
55. T. Batuwangala, M. Leduc, J.M. Gibbins, C. Bon and E.Y. Jones (2004) Structure of the snake-venom toxin convulxin. Acta Crystallogr D Biol Crystallogr 60(Pt 1), 46-53.
56. O. Inoue, K. Suzuki-Inoue, O.J. McCarty, M. Moroi, Z.M. Ruggeri, T.J. Kunicki, et al. (2006) Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood 107(4), 1405-1412.
57. O. Inoue, K. Suzuki-Inoue and Y. Ozaki (2008) Redundant mechanism of platelet adhesion to laminin and collagen under flow: involvement of von Willebrand factor and glycoprotein Ib-IX-V. J Biol Chem 283(24), 16279-16282.
58. R. Riba, C.E. Hughes, A. Graham, S.P. Watson and K.M. Naseem (2008) Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost 6(6), 1012-1020.
59. S.P. Watson, B. Reep, R.T. McConnell and E.G. Lapetina (1985) Collagen stimulates [3H]inositol trisphosphate formation in indomethacin-treated human platelets. Biochem J 226(3), 831-837.
60. R.A. Blake, G.L. Schieven and S.P. Watson (1994) Collagen stimulates tyrosine phosphorylation of phospholipase C-gamma 2 but not phospholipase C-gamma 1 in human platelets. FEBS Lett 353(2), 212-216.
61. A.W. Poole and S.P. Watson (1995) Regulation of cytosolic calcium by collagen in single human platelets. Br J Pharmacol 115(1), 101-106.
62. F. Yanaga, A. Poole, J. Asselin, R. Blake, G.L. Schieven, E.A. Clark, et al. (1995) Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. Biochem J 311(Pt. 2), 471-478.
63. O. Berlanga, D. Tulasne, T. Bori, D.C. Snell, Y. Miura, S. Jung, et al. (2002) The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin. Eur J Biochem 269(12), 2951-2960.
64. K. Kato, T. Kanaji, S. Russell, T.J. Kunicki, K. Furihata, S. Kanaji, et al. (2003) The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102(5), 1701-1707.
65. M. Reth (1989) Antigen receptor tail clue. Nature 338(6214), 383-384.
66. D. Locke, H. Chen, Y. Liu, C. Liu and M.L. Kahn (2002) Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI. J Biol Chem 277(21), 18801-18809.
67. P. Wonerow, A. Obergfell, J.I. Wilde, R. Bobe, N. Asazuma, T. Brdicka, et al. (2002) Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem J 364(Pt. 3), 755-765.
68. A.A. Schmaier, Z. Zou, A. Kazlauskas, L. Emert-Sedlak, K.P. Fong, K.B. Neeves, et al. (2009) Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proc Natl Acad Sci USA 106(50), 21167-21172.
69. T. Bori-Sanz, K.S. Inoue, M.C. Berndt, S.P. Watson and D. Tulasne (2003) Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain. J Biol Chem 278(38), 35914-35922.
70. L.S. Quek, J.M. Pasquet, I. Hers, R. Cornall, G. Knight, M. Barnes, et al. (2000) Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 96(13), 4246-4253.
71. K. Gilio, I.C. Munnix, P. Mangin, J.M. Cosemans, M.A. Feijge, P.E. van der Meijden, et al. (2009) Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J Biol Chem 284(49), 33750-33762.
72. S. Kim, P. Mangin, C. Dangelmaier, R. Lillian, S.P. Jackson, J.L. Daniel, et al. (2009) Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets. J Biol Chem 284(49), 33763-33772.
73. B.T. Atkinson, W. Ellmeier and S.P. Watson (2003) Tec regulates platelet activation by GPVI in the absence of Btk. Blood 102(10), 3592-3599.
74. A.C. Pearce, Y.A. Senis, D.D. Billadeau, M. Turner, S.P. Watson, E. Vigorito, et al. (2004) Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J Biol Chem 279(52), 53955-53962.
75. M.C. Berndt, D. Karunakaran, E.E. Gardiner and R.K. Andrews (2007) Programmed autologous cleavage of platelet receptors. J Thromb Haemost 5(Suppl. 1), 212-219.
76. M. Al-Tamimi, G. Grigoriadis, H. Tran, E. Paul, P. Servadei, M.C. Berndt, et al. (2011) Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood 117(14), 3912-3920.
77. B. Nieswandt, V. Schulte, W. Bergmeier, R. Mokhtari-Nejad, K. Rackebrandt, J.P. Cazenave, et al. (2001) Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 193(4), 459-469.
78. B. Boylan, M.C. Berndt, M.L. Kahn and P.J. Newman (2006) Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood 108(3), 908-914.
79. H. Takayama, Y. Hosaka, K. Nakayama, K. Shirakawa, K. Naitoh, T. Matsusue, et al. (2008) A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex. J Clin Invest 118(5), 1785-1795.
80. B. Hechler, C. Nonne, A. Eckly, S. Magnenat, J.Y. Rinckel, C.V. Denis, et al. (2010) Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization. J Thromb Haemost 8(1), 173-184.
81. N. Kalia, J.M. Auger, B. Atkinson and S.P. Watson (2008) Critical role of FcR gamma-chain, LAT, PLCgamma2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo. Microcirculation 15(4), 325-335.
82. W.S. Nesbitt, E. Westein, F.J. Tovar-Lopez, E. Tolouei, A. Mitchell, J. Fu, et al. (2009) A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 15(6), 665-673.
83. B. Ho-Tin-Noe, M. Demers and D.D. Wagner (2011) How platelets safeguard vascular integrity. J Thromb Haemost 9(Suppl. 1), 56-65.
84. K. Echtler, K. Stark, M. Lorenz, S. Kerstan, A. Walch, L. Jennen, et al. (2010) Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16(1), 75-82.
85. E. Boilard, P.A. Nigrovic, K. Larabee, G.F. Watts, J.S. Coblyn, M.E. Weinblatt, et al. (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327(5965), 580-583.
86. I.C. Munnix, A. Strehl, M.J. Kuijpers, J.M. Auger, P.E. van der Meijden, M.A. van Zandvoort, et al. (2005) The glycoprotein VI-phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo. Arterioscler Thromb Vasc Biol 25(12), 2673-2678.
87. S. Penz, A.J. Reininger, R. Brandl, P. Goyal, T. Rabie, I. Bernlochner, et al. (2005) Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 19(8), 898-909.
88. M. Colonna, J. Samaridis and L. Angman (2000) Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur J Immunol 30(2), 697-704.
89. A.M. Kerrigan, K.M. Dennehy, D. Mourao-Sa, I. Faro-Trindade, J.A. Willment, P.R. Taylor, et al. (2009) CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J Immunol 182(7), 4150-4157.
90. D. Mourao-Sa, M.J. Robinson, S. Zelenay, D. Sancho, P. Chakravarty, R. Larsen, et al. (2011) CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol
91. J. Xie, T. Wu, L. Guo, Y. Ruan, L. Zhou, H. Zhu, et al. (2008) Molecular characterization of two novel isoforms and a soluble form of mouse CLEC-2. Biochem Biophys Res Commun 371(2), 180-184.
92. Y.A. Senis, M.G. Tomlinson, A. Garcia, S. Dumon, V.L. Heath, J. Herbert, et al. (2007) A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics 6(3), 548-564.
93. C. Huysamen and G.D. Brown (2009) The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol Lett 290(2), 121-128.
94. A.A. Watson, C.M. Christou, J.R. James, A.E. Fenton-May, G.E. Moncayo, A.R. Mistry, et al. (2009) The platelet receptor CLEC-2 is active as a dimer. Biochem 48(46), 10988-10996.
95. C.E. Hughes, A.Y. Pollitt, J. Mori, J.A. Eble, M.G. Tomlinson, J.H. Hartwig, et al. (2010) CLEC-2 activates Syk through dimerization. Blood 115(14), 2947-2955.
96. T.F. Huang, C.Z. Liu and S.H. Yang (1995) Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem J 309(Pt. 3), 1021-1027.
97. Y. Shin and T. Morita (1998) Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib. Biochem Biophys Res Commun 245(3), 741-745.
98. K. Suzuki-Inoue, Y. Ozaki, M. Kainoh, Y. Shin, Y. Wu, Y. Yatomi, et al. (2001) Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin alpha 2beta 1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation. J Biol Chem 276(2), 1643-1652.
99. A. Navdaev, J.M. Clemetson, J. Polgar, B.E. Kehrel, M. Glauner, E. Magnenat, et al. (2001) Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to alpha2beta1 integrin and glycoprotein Ib, activating Syk and phospholipase Cgamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor. J Biol Chem 276(24), 20882-20889.
100. J.A. Eble, B. Beermann, H.J. Hinz and A. Schmidt-Hederich (2001) alpha 2beta 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J Biol Chem 276(15), 12274-12284.
101. W. Bergmeier, D. Bouvard, J.A. Eble, R. Mokhtari-Nejad, V. Schulte, H. Zirngibl, et al. (2001) Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha. J Biol Chem 276(27), 25121-25126.
102. K. Suzuki-Inoue, G.L. Fuller, A. Garcia, J.A. Eble, S. Pohlmann, O. Inoue, et al. (2006) A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107(2), 542-549.
103. G.L. Fuller, J.A. Williams, M.G. Tomlinson, J.A. Eble, S.L. Hanna, S. Pohlmann, et al. (2007) The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem 282(17), 12397-12409.
104. A.A. Watson, J. Brown, K. Harlos, J.A. Eble, T.S. Walter, C.A. O’Callaghan, et al. (2007) The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2. J Biol Chem 282(5), 3165-3172.
105. E. Hooley, E. Papagrigoriou, A. Navdaev, A.V. Pandey, J.M. Clemetson, K.J. Clemetson, et al. (2008) The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure. Biochem 47(30), 7831-7837.
106. J.C. Spalton, J. Mori, A.Y. Pollitt, C.E. Hughes, J.A. Eble, S.P. Watson, et al. (2009) The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost 7(7), 1192-1199.
107. S. Severin, A.Y. Pollitt, L. Navarro-Nunez, C.A. Nash, D. Mourao-Sa, J.A. Eble, et al. (2011) Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J Biol Chem 286(6), 4107-4116.
108. C. Chaipan, E.J. Soilleux, P. Simpson, H. Hofmann, T. Gramberg, A. Marzi, et al. (2006) DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 80(18), 8951-8960.
109. C.M. Christou, A.C. Pearce, A.A. Watson, A.R. Mistry, A.Y. Pollitt, A.E. Fenton-May, et al. (2008) Renal cells activate the platelet receptor CLEC-2 through podoplanin. Biochem J 411(1), 133-140.
110. C. Chaipan, I. Steffen, T.S. Tsegaye, S. Bertram, I. Glowacka, Y. Kato, et al. (2010) Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2. Retrovirology 7 47.
111. K. Suzuki-Inoue, Y. Kato, O. Inoue, M.K. Kaneko, K. Mishima, Y. Yatomi, et al. (2007) Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 282(36), 25993-26001.
112. V. Schacht, S.S. Dadras, L.A. Johnson, D.G. Jackson, Y.K. Hong, M. Detmar, et al. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166(3), 913-921.
113. T.Z. Hou, J. Bystrom, J.P. Sherlock, O. Qureshi, S.M. Parnell, G. Anderson, et al. (2010) A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis. FEBS Lett 584(18), 3955-3961.
114. C.E. Hughes, J.M. Auger, J. McGlade, J.A. Eble, A.C. Pearce, S.P. Watson, et al. (2008) Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2. J Thromb Haemost 6(12), 2152-2159.
115. A.Y. Pollitt, B. Grygielska, B. Leblond, L. Desire, J.A. Eble and S.P. Watson (2010) Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood 115(14), 2938-2946.
116. F. May, I. Hagedorn, I. Pleines, M. Bender, T. Vogtle, J. Eble, et al. (2009) CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 114(16), 3464-3472.
117. K. Suzuki-Inoue, O. Inoue and Y. Ozaki (2011) Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost 9(Suppl. 1), 44-55.
118. K. Suzuki-Inoue, O. Inoue, G. Ding, S. Nishimura, K. Hokamura, K. Eto, et al. (2010) Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 285(32), 24494-24507.
119. C.E. Hughes, L. Navarro-Nunez, B.A. Finney, D. Mourao-Sa, A.Y. Pollitt, S.P. Watson, et al. (2010) CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost 8(10), 2328-2332.
120. C.C. Bertozzi, A.A. Schmaier, P. Mericko, P.R. Hess, Z. Zou, M. Chen, et al. (2010) Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116(4), 661-670.
121. T. Tang, L. Li, J. Tang, Y. Li, W.Y. Lin, F. Martin, et al. (2010) A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 28(7), 749-755.
122. F. Abtahian, A. Guerriero, E. Sebzda, M.M. Lu, R. Zhou, A. Mocsai, et al. (2003) Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299(5604), 247-251.
123. E. Sebzda, C. Hibbard, S. Sweeney, F. Abtahian, N. Bezman, G. Clemens, et al. (2006) Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev Cell 11(3), 349-361.
124. H. Ichise, T. Ichise, O. Ohtani and N. Yoshida (2009) Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 136(2), 191-195.
125. V. Schacht, M.I. Ramirez, Y.K. Hong, S. Hirakawa, D. Feng, N. Harvey, et al. (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 22(14), 3546-3556.
126. P. Uhrin, J. Zaujec, J.M. Breuss, D. Olcaydu, P. Chrenek, H. Stockinger, et al. (2010) Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115(19), 3997-4005.
127. J. Fu, H. Gerhardt, J.M. McDaniel, B. Xia, X. Liu, L. Ivanciu, et al. (2008) Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 118(11), 3725-3737.
128. L. Carramolino, J. Fuentes, C. Garcia-Andres, V. Azcoitia, D. Riethmacher, M. Torres, et al. (2010) Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res 106(7), 1197-1201.
129. L. Navarro-Núñez, B.A. Finney, G.B. Nash and S.P. Watson (2011) Platelets regulate the formation of the lymphatic vasculature by modulating the migratory potential of lymphatic endothelial cells. J Thromb Haemost 9(Suppl. 2), 760.
130. M. Osada, O. Inoue, G. Ding, M. Hirashima, Y. Ozaki, K. Suzuki-Inoue, et al. (2011) CLEC-2 regulates lymphangiogenesis by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Thromb Haemost 9(Suppl. 2), 43.
131. B.A. Finney, E. Schweighoffer, L. Navarro-Nunez, C. Benezech, F. Barone, C.E. Hughes, et al. (2012) CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood 119(7), 1747-1756.
132. F.G. Scholl, C. Gamallo, S. Vilaro and M. Quintanilla (1999) Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci 112(Pt. 24), 4601-4613.
133. K. Koop, M. Eikmans, M. Wehland, H. Baelde, D. Ijpelaar, R. Kreutz, et al. (2008) Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model. Am J Pathol 173(2), 315-326.